• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problem Occlusion (1984)
Event Date 06/01/2019
Event Type  Injury  
Manufacturer Narrative
Review of the manufacturing records could not be completed as no lot number information was provided.The device was not returned.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.Note: this event was originally reported to fda in medwatch #2017233-2019-00481 & #2017233-2019-00483.This report addresses the non specific device occlusion of the same event.
 
Event Description
The following was reported to gore: on an unknown date, a biliary metallic stent (mfg unknown) was placed to treat unresectable pancreatic head cancer.The patient also received chemotherapy at that time.After treatment, the patient vomited blood frequently.Pseudoaneurysm in the proximal part of superior mesenteric artery associated with infection was observed by the doctor.To treat the pseudoaneurysm, a gore® viabahn® endoprostheses was placed and dual antiplatelet therapy (dapt) was performed.Over the course of treatment, a second gore® viabahn® endoprostheses was implanted.On an unknown date ct revealed occlusion of the gore® viabahn® endoprostheses and air was observed inside/outside of the gore® viabahn® endoprostheses.The doctor confirmed that mesenteric ischemia was not present.Biliary metallic stent breakage was also observed at this time.The doctor reported that the biliary metallic stent break contributed to occlusion of the gore® viabahn® endoprostheses.Symptoms of infection were noted and the patient was discharged from the hospital with the absence of any bleeding.
 
Manufacturer Narrative
Corrected data: b3 - date of event.
 
Manufacturer Narrative
Corrected data: g5 - combination product, g5 - pre-1938, g5 - otc product.
 
Manufacturer Narrative
Additional manufacturer narrative: b7 - other relevant history, including preexisting medical conditions.D5 - operator of device.G5 - combination product.G5 - pre-1938.G5 - otc product.Two gore® viabahn® endoprostheses were involved in this reported event.See manufacturer report # 2017233-2019-00696.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8918598
MDR Text Key155180292
Report Number2017233-2019-00697
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 10/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/21/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received10/24/2019
10/25/2019
10/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-